- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05497791
Stroke, Measurement and Rehabilitation (LTNMES)
Stroke, Measurement and Rehabilitation With Transcranial Laser Stimulation Plus Neuromuscular Electrical Stimulation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
São Paulo
-
São Carlos, São Paulo, Brazil, 13569600
- Fernanda Rossi Paolillo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female and male aged between 35 and 75 years with hemiplegia after stroke (more than 12 months from onset) as well as those who experienced only one episode of stroke.
Exclusion Criteria:
- Bedridden stroke patients, who had great difficulty standing and walking, psychiatric illnesses, endocrinopathies, heart diseases, severe osteoporosis, cancer, musculoskeletal injuries or disorders in the last six months as well as practitioners of regular physical activity, physical therapy or occupational therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Transcranial Laser and Electrical Stimulation
Hemiplegics treated with transcranial laser stimulation (on) associated with neuromuscular electrical stimulation (NMES) (on)
|
The cluster was applied on the skin covering the head. NMES of the paretic limbs was programmed to generate, alternately, ankle dorsiflexion and wrist extension. The NMES was started, after 5 minutes the transcranial laser stimulation (active or placebo-treatment) was started. Then, the therapies were combined. After finishing the transcranial laser stimulation (active or placebo-treatment), the NMES was continued until completing 30 minutes. |
|
Placebo Comparator: Placebo
Hemiplegics treated with placebo transcranial laser stimulation (off) associated with NMES (on)
|
The transcranial laser was applied identically for all groups, but the null dose was used in the placebo group.
NMES of the paretic limbs was programmed to generate, alternately, ankle dorsiflexion and wrist extension.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inertial Sensor
Time Frame: 3 months
|
Angular measurement of the upper and lower limbs using an inertial sensor.
|
3 months
|
|
Subjective pain scale
Time Frame: 3 months
|
Visual Analogue Scales (VAS) of pain intensity: A continuous scale comprised of a horizontal line with 10 cm in length without numeric value was used.
The patients were instructed to make a mark with a pen at any point on the line between 2 verbal descriptors, one for each symptom extreme ["No pain" (0) and "as bad as it could be" or "worst imaginable pain].
A ruler was used to measure distance to determine a score.
|
3 months
|
|
Cognitive status
Time Frame: 3 months
|
Mini-Mental State Examination: It comprises 11-question to evaluated 5 areas of cognitive function: orientation, registration, attention and calculation, memory, and language.
MMSE scores range between 0 and 30, with higher scores reflecting better performance
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grip strength
Time Frame: 3 months
|
Hand dynamometer: Grip strength of the paretic limb was measured by the hand dynamometer with patients sitting with the shoulder in a neutral position and the elbow flexed at 90°.
The average force of three measurements was calculated
|
3 months
|
|
Gross manual dexterity
Time Frame: 3 months
|
Box and block test: Gross manual dexterity of the paretic member was measured by the box and block test.
The patient must attempt to transport the maximum number of blocks from one compartment of a box to another within 1 minute by grasping each block and transporting it over the partition.
|
3 months
|
|
Dynamic balance
Time Frame: 3 months
|
Timed Up and Go (TUG) test: Patients were required to stand up from a chair, walk 3m, turn around, return to the chair, and sit down.
The time taken to complete this task was measured with a stopwatch.
|
3 months
|
|
Spasticity
Time Frame: 3 months
|
Ashworth Scale: It is 6-point rating scale for measuring muscle tone, with ratings from 0 ("no increase in tone") to 4 ("limb rigid in flexion or extension").
|
3 months
|
|
Functional status
Time Frame: 3 months
|
Functional Independence Measure Scale™ (FIM): It is an instrument which comprises 18 subscales measuring a variety of physical and cognitive functions.
Each subscale is scored from 1 (total assist) to 7 (complete independence), resulting in a total score that ranges from 18 to 126.
|
3 months
|
|
Quality of Life status
Time Frame: 3 months
|
World Health Organization Quality of Life-Abbreviated form (WHOQOL-BREF): a 26-item questionnaire in which items are rated on a 5-point scale.
It evaluates 4 domains related to physical factors, psychological factors, social relationships, and environmental context.
Higher scores indicate a better quality of life.
|
3 months
|
|
Well-Being status
Time Frame: 3 months
|
Subjective Well-Being Scale (EBES): It is composed of 62 items related to three factors that evaluate subjective well-being: positive affect; negative affection and satisfaction with life versus life dissatisfaction.
The first 47 items measure positive and negative affect using a 5-point scale with ratings from "not at all" to "to a great extent".
The last 22 items measure life satisfaction (or dissatisfaction) using a 5-point scale with ratings from "strongly disagree" to "strongly agree".
|
3 months
|
|
Thermography
Time Frame: 3 months
|
Cutaneous temperatures were measurements at 2 regions of the head [parietal (with hair) and frontal (without hair) regions] and 6 points on upper and lower limbs.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fernanda R Paolillo, PhD, UEMG
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STROkE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on transcranial laser stimulation associated with NMES
-
Federal University of Health Science of Porto AlegreRecruitingAnterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament Reconstruction RehabilitationBrazil
-
Cairo UniversityCompletedMotor Neuropathy | Neuropathy, Peroneal | Neuromuscular Electric Stimulation (NEMS) | Low Intensity LaserEgypt
-
Anhui Medical UniversityRecruitingTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Accelerated Continue Theta-burst StimulationChina
-
Anhui Medical UniversityCompletedTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Event-Related PotentialsChina
-
Zhifen LiuRecruiting
-
University of ArkansasRecruiting
-
Anhui Medical UniversityUnknownTranscranial Magnetic Stimulation | Treatment Resistant Depression | Functional Magnetic Resonance Imaging | Event-Related PotentialsChina
-
Shanghai Mental Health CenterRecruitingTreatment Resistant Schizophrenia Based on the DTMSChina
-
Anhui Medical UniversityUnknownMajor Depressive Disorder | Transcranial Direct Current Stimulation | Event-Related PotentialsChina
-
University of Texas at AustinMilken Institute; Baszucki Brain Research FundNot yet recruiting